CIBC Asset Management’s Amedisys AMED Stock Holding History

CIBC Asset Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,315	Closed	-$227K	–	1279
2022 Q1	$227K	Hold	1,315	–	–	﹤0.01%	1267
2021 Q4	$213K	Buy	+1,315	New	+$211K	﹤0.01%	1355
2021 Q3	–	Sell	-1,220	Closed	-$299K	–	1461
2021 Q2	$299K	Hold	1,220	–	–	﹤0.01%	997
2021 Q1	$323K	Sell	1,220 -40	-3%	-$11.3K	﹤0.01%	932
2020 Q4	$370K	Hold	1,260	–	–	﹤0.01%	820
2020 Q3	$298K	Buy	1,260 +31	+3%	+$7.05K	﹤0.01%	835
2020 Q2	$244K	Hold	1,229	–	–	﹤0.01%	879
2020 Q1	$226K	Hold	1,229	–	–	﹤0.01%	823
2019 Q4	$205K	Buy	+1,229	New	+$183K	﹤0.01%	1073
2017 Q4	–	Sell	-3,692	Closed	-$207K	–	1070
2017 Q3	$207K	Buy	3,692 +28	+0.8%	+$1.48K	﹤0.01%	947
2017 Q2	$230K	Buy	+3,664	New	+$213K	﹤0.01%	869

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CIBC Asset Management's AMED Position: Q2 2022 in Review

CIBC Asset Management sold out of Amedisys (AMED) in Q2 2022, closing a stake of 1,315 shares — an estimated $227K sold.

CIBC Asset Management first reported a position in AMED in Q2 2017 and held it in 11 quarters. The position peaked at $370K in Q4 2020. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

CIBC Asset Management reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
CIBC Asset Management sold 1,315 Amedisys shares in Q2 2022, an estimated $227K.
CIBC Asset Management first reported a position in Amedisys in Q2 2017 and held it in 11 quarters.
CIBC Asset Management's Amedisys position peaked at $370K in Q4 2020.
288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on CIBC Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.